Pathway Diagnostics: Biomarker Development, Testing and Commercialization Ask Us How

Corporate

Pathway Diagnostics is an innovator in the development of novel biomarker assays. Integrating biomarker testing services for pharma clinical trials with a growing portfolio of proprietary assay technology, we aim to bring to market the next generation of diagnostic tools. Our corporate headquarters and laboratory comprise 20,000 square feet of a landmark technology office park campus in Malibu, California.

What's New "Announcing SensiTrop™ II HIV co-receptor tropism assay, combining the sensitivity of heteroduplex tracking and the specificity of DNA sequence analysis "
©2007 PathwayDX.com. Privacy Policy.